Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Total 13F shares
-
16,864,477
-
Share change
-
-24,696
-
Total reported value
-
$88,888,097
-
Put/Call ratio
-
200%
-
Price per share
-
$5.27
-
Number of holders
-
70
-
Value change
-
-$685,228
-
Number of buys
-
34
-
Number of sells
-
28
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q3 2019
As of 30 Sep 2019,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,864,477 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, 683 Capital Management, LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., Prosight Management, LP, MILLENNIUM MANAGEMENT LLC, and Knoll Capital Management, LP.
This page lists
70
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.